Prescribers and Naloxone Pharmacy Claims
J Gen Intern Med
.
2020 Aug;35(8):2475.
doi: 10.1007/s11606-020-05791-5.
Authors
Rosanna Smart
1
,
Caroline K Geiger
2
,
Christopher M Jones
3
,
Bradley D Stein
4
5
Affiliations
1
RAND Corporation, 1776 Main Street, Santa Monica, CA, 90407-2138, USA.
[email protected]
.
2
Harvard University, Cambridge, USA.
3
Centers for Disease Control and Prevention, Atlanta, USA.
4
RAND Corporation, 1776 Main Street, Santa Monica, CA, 90407-2138, USA.
5
University of Pittsburgh School of Medicine, Pittsburgh, USA.
PMID:
32212092
PMCID:
PMC7403255
DOI:
10.1007/s11606-020-05791-5
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
MeSH terms
Humans
Naloxone
Pharmaceutical Services*
Pharmacies*
Pharmacy*
Prescriptions
Substances
Naloxone
Grants and funding
P50 DA046351/DA/NIDA NIH HHS/United States
R21 DA045950/DA/NIDA NIH HHS/United States